rs11557600

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000355.4(TCN2):​c.280G>A​(p.Gly94Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00253 in 1,613,952 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G94C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 7 hom. )

Consequence

TCN2
NM_000355.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0400

Publications

6 publications found
Variant links:
Genes affected
TCN2 (HGNC:11653): (transcobalamin 2) This gene encodes a member of the vitamin B12-binding protein family. This family of proteins, alternatively referred to as R binders, is expressed in various tissues and secretions. This plasma protein binds cobalamin and mediates the transport of cobalamin into cells. This protein and other mammalian cobalamin-binding proteins, such as transcobalamin I and gastric intrisic factor, may have evolved by duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
TCN2 Gene-Disease associations (from GenCC):
  • transcobalamin II deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038371682).
BP6
Variant 22-30612895-G-A is Benign according to our data. Variant chr22-30612895-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 440324.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0021 (320/152308) while in subpopulation AMR AF = 0.0032 (49/15294). AF 95% confidence interval is 0.00273. There are 0 homozygotes in GnomAd4. There are 149 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000355.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TCN2
NM_000355.4
MANE Select
c.280G>Ap.Gly94Ser
missense
Exon 3 of 9NP_000346.2
TCN2
NM_001184726.2
c.280G>Ap.Gly94Ser
missense
Exon 3 of 9NP_001171655.1P20062-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TCN2
ENST00000215838.8
TSL:1 MANE Select
c.280G>Ap.Gly94Ser
missense
Exon 3 of 9ENSP00000215838.3P20062-1
TCN2
ENST00000407817.3
TSL:1
c.280G>Ap.Gly94Ser
missense
Exon 3 of 9ENSP00000384914.3P20062-2
TCN2
ENST00000947107.1
c.280G>Ap.Gly94Ser
missense
Exon 3 of 10ENSP00000617166.1

Frequencies

GnomAD3 genomes
AF:
0.00210
AC:
320
AN:
152190
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00806
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00307
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00212
AC:
533
AN:
251304
AF XY:
0.00205
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.00179
Gnomad ASJ exome
AF:
0.00784
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.00313
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.00257
AC:
3761
AN:
1461644
Hom.:
7
Cov.:
32
AF XY:
0.00254
AC XY:
1848
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33476
American (AMR)
AF:
0.00199
AC:
89
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00689
AC:
180
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.000638
AC:
55
AN:
86252
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53382
Middle Eastern (MID)
AF:
0.00286
AC:
16
AN:
5600
European-Non Finnish (NFE)
AF:
0.00293
AC:
3261
AN:
1111990
Other (OTH)
AF:
0.00232
AC:
140
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
239
477
716
954
1193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00210
AC:
320
AN:
152308
Hom.:
0
Cov.:
33
AF XY:
0.00200
AC XY:
149
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000577
AC:
24
AN:
41572
American (AMR)
AF:
0.00320
AC:
49
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00806
AC:
28
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00307
AC:
209
AN:
68036
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00281
Hom.:
2
Bravo
AF:
0.00241
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00199
AC:
242
EpiCase
AF:
0.00344
EpiControl
AF:
0.00314

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Transcobalamin II deficiency (5)
-
-
3
not provided (3)
-
-
1
not specified (1)
-
-
1
TCN2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.12
DANN
Benign
0.61
DEOGEN2
Benign
0.018
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.33
T
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.0038
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-2.8
N
PhyloP100
-0.040
PrimateAI
Benign
0.27
T
PROVEAN
Benign
1.2
N
REVEL
Benign
0.018
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.12
MVP
0.055
MPC
0.0092
ClinPred
0.0042
T
GERP RS
1.9
Varity_R
0.017
gMVP
0.12
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11557600; hg19: chr22-31008882; COSMIC: COSV105076384; COSMIC: COSV105076384; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.